CC-90006
- Generic Name
- CC-90006
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Celgene
- Target Recruit Count
- 34
- Registration Number
- NCT03337022
- Locations
- 🇨🇦
Innovaderm Research, Montreal, Quebec, Canada
🇺🇸TKL Research, Fair Lawn, New Jersey, United States
🇺🇸Anaheim Clinical Trials, LLC, Anaheim, California, United States
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2018-02-08
- Lead Sponsor
- Celgene
- Target Recruit Count
- 40
- Registration Number
- NCT02934269
- Locations
- 🇺🇸
PPD Phase 1 Unit, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath